HOME >> BIOLOGY >> NEWS
Cardiac Clinical Trial Studies Use of Antibiotic In Preventing Heart Attack

HIGHLIGHTS: A clinical trial currently under way at Cedars-Sinai Medical Center could have profound ramifications for preventing recurring heart attacks by using a common, inexpensive antibiotic. AVAILABLE FOR INTERVIEWS: Bojan Cercek, M.D., Ph.D., Director, Coronary Care Unit, Cedars-Sinai Medical Center P.K.Shah, M.D., Chairman, Division of Cardiology, Cedars-Sinai Medical Center; Professor of Medicine, UCLA School of Medicine. LOS ANGELES (November 12, 1998) - A common, inexpensive antibiotic could reduce a second heart attack in patients who have already suffered an acute heart attack. In a clinical trial involving 1,400 patients, Cedars-Sinai Medical Center scientists, as well as collaborators at two facilities in Israel and three in Europe, are testing the effectiveness of the common antibiotic, Azithromycin, in preventing recurrent heart attacks.

"Of people who have just had a heart attack, 20 to 25 percent are likely to have another heart attack within the next six months," says Bojan Cercek, M.D., Ph.D., Lead Investigator and Director of the Coronary Care Unit at Cedars-Sinai.

"There is a growing body of scientific evidence implicating ongoing inflammation (accumulation of white blood cells) in plaque formation and plaque disruption that leads to blood clots and heart attacks, says P.K.Shah, M.D., Chairman of Cardiology at Cedars-Sinai.

According to Dr. Shah, "Cholesterol accumulation inside the plaque provides one of the stimuli for inflammation; the other may be bacterial/viral infection of the plaque. Therefore we designed the current AZACS study to determine the potential value of antibiotics for heart attack prevention."

"Chlamydia pneumonia, a common bacteria that causes respiratory infections, has been identified in 30 to 40 percent of plaques where it may stimulate the white blood cells to trigger a heart attack," says Dr. Cercek. "If this hypothesis is correct, treating the patient with the antibiotic Azithromycin
'"/>

Contact: Sandra Van
sandy@vancommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
13-Nov-1998


Page: 1 2

Related biology news :

1. Cardiac arrest may hinder ability to learn certain tasks
2. Cardiac stress tests may indicate if blockages will recur after angioplasty with stent implant
3. Cardiac surgery patients at higher risk
4. Sudden Cardiac Death May Run In Families
5. New Company Formed Through Licensing Of Cardiac-Hypertrophy Technology From Texas Institutions
6. Strategic Placement Of Automated External Defibrillators May Help Save Lives Of People Who Go Into Cardiac Arrest
7. Evaluation Of The Two Types Of Cardiac Pacemakers Indicates Only Modest Differences In Value
8. Family Ties To Sudden Cardiac Arrest; Study Finds Risk Goes Up 50 Percent
9. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
10. Researchers Find Association Between Alzheimers Gene And Mental Impairment After Cardiac Surgery
11. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... 2020 , ... Mosio recently announced its newly updated text ... of all sizes. With a focus on tracking symptoms and monitoring outbreaks as ... Mosio helps public health departments automate communications and provide more personalized care and ...
(Date:8/3/2020)... ... 03, 2020 , ... Accumen Inc. is helping healthcare get ... Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. , “Accumen has ... than 10 years. Early in the COVID-19 crisis, we identified supply chain gaps ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device ... The study reported that the Neoasis™ device attenuated the alarm sounds from patient ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... BINGHAM FARMS, Mich. (PRWEB) , ... August 12, ... ... International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ...
(Date:7/31/2020)... , ... July 29, 2020 , ... R3 Stem Cell ... for only $3950. With 50 million stem cells total, patients may choose which extremities ... therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord ...
(Date:7/31/2020)... N.J (PRWEB) , ... July 29, 2020 , ... ... company, and Catalent, the leading global provider of advanced delivery technologies, development, and ... today announced that they have entered into a strategic partnership whereby Catalent will ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
Breaking Biology Technology:
Cached News: